Therapeutic flag Cosmetic cross-reference

Sodium Hypochlorite

CAS 7681-52-9

Sodium Hypochlorite (CAS 7681-52-9) is a Phase 3 pharmaceutical compound with 1 bioactivity target and 6 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Sodium Hypochlorite

CAS Number

7681-52-9

UNII

DY38VHM5OD

InChIKey

SUKJFIGYRHOWBL-UHFFFAOYSA-N

ChEMBL ID

CHEMBL1334078

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

therapeutic flag

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3

Late-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL1334078 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Potency	1186 nM	2	-

SOURCE DrugCentral 2 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PT	Drug AE	LLR	MedDRA
Completed suicide	44	94.53	10010144
Toxicity to various agents	33	41.788	10070863

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
Sodium Hypochlorite	9881	SU	MTHSPL
SODIUM HYPOCHLORITE	9881	SU	MTHSPL
sodium hypochlorite	9881	PIN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Sodium Hypochlorite used for in pharmaceutical contexts?

Sodium Hypochlorite (CAS 7681-52-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Sodium Hypochlorite?

Sodium Hypochlorite has 6 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Completed suicide, Toxicity to various agents, Application site erosion, Illness, Off label use. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Sodium Hypochlorite also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Hypochlorite with EU status "prohibited".

What clinical phase is Sodium Hypochlorite in?

Sodium Hypochlorite is rendered with ChEMBL max phase 3.